Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells

Cancer Immunology Immunotherapy(2021)10.1007/s00262-021-02969-6Source: DataRank Database

CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells is a research paper published in Cancer Immunology Immunotherapy (2021). On theSindex it has a DataRank of 0. It has been cited 28 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access28 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)OA: greenTopics (46)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Toshifumi Hoki ORCID,Takaaki Oba,Ryutaro Kajihara ORCID,Kristopher Attwood ORCID,Xuefang Cao ORCID

Live enrichment

PubMed:34037810 PMC:PMC8715856

National Cancer Institute

Grant: P30CA016056

NIH/NCI

Grant: K08CA197966

NIH

Grant: R01HL135325

NIAID NIH HHS

Grant: HHSN272201300006C

National Institutes of Health

Grant: 5P30CA016056-40

Roswell Park Cancer Institute Cancer Center Support Grant

National Institutes of Health

Grant: 5R01HL135325-03

CD27/CD70 mediated negative regulation of inflammatory T cell responses

National Institutes of Health

Grant: 5K08CA197966-06

Adoptive Cell Therapy with Rejuvenated Antigen-Specific T Cells

Nakatomi Foundation

Uehara Memorial Foundation

Astellas Foundation for Research on Metabolic Disorders

Roswell Park Alliance Foundation, Roswell Park Cancer Institute

greenLicense: Springer TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8715856

publisherhttps://link.springer.com/content/pdf/10.1007/s00262-021-02969-6.pdf

publisherhttps://link.springer.com/article/10.1007/s00262-021-02969-6/fulltext.html

https://doi.org/10.1007/s00262-021-02969-6

https://pubmed.ncbi.nlm.nih.gov/34037810

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Dendritic CellsT-LymphocytesCD8-Positive T-LymphocytesCell Line, TumorAnimalsMice, Inbred C57BLMiceCancer VaccinesVaccinationNeoplasm TransplantationSignal TransductionMutationFemaleToll-Like Receptor 3Biomarkers, TumorCX3C Chemokine Receptor 1B7-1 AntigenCD40 AntigensB7-2 Antigen

Keywords

T cellsDendritic cellsBiomarkerNeoantigenVaccine TherapyCx3cr1T-LymphocytesVaccinationCX3C Chemokine Receptor 1CD8-Positive T-LymphocytesCancer VaccinesToll-Like Receptor 3Mice, Inbred C57BLMiceCell Line, TumorMutationB7-1 AntigenBiomarkers, TumorAnimalsFemaleB7-2 AntigenCD40 AntigensNeoplasm TransplantationSignal Transduction

Sustainable Development Goals

SDG 3: 3. Good health